Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma

Mariam A. Stoff-Khalili, Angel A. Rivera, J. Michael Mathis, N. Sanjib Banerjee, Amanda S. Moon, A. Hess, Rodney P. Rocconi, T. Michael Numnum, M. Everts, Louise T. Chow, Joanne T. Douglas, Gene P. Siegal, Zeng B. Zhu, Hans Georg Bender, Peter Dall, Alexander Stoff, Larissa Pereboeva, David T. Curiel

Research output: Contribution to journalArticle

141 Scopus citations

Abstract

Purpose: Alternative and complementary therapeutic strategies need to be developed for metastatic breast cancer. Virotherapy is a novel therapeutic approach for the treatment of cancer in which the replicating virus itself is the anticancer agent. However, the success of virotherapy has been limited due to inefficient virus delivery to the tumor site. The present study addresses the utility of human mesenchymal stem cells (hMSCs) as intermediate carriers for conditionally replicating adenoviruses (CRAds) to target metastatic breast cancer in vivo. Experimental design: HMSC were transduced with CRAds. We used a SCID mouse xenograft model to examine the effects of systemically injected CRAd loaded hMSC or CRAd alone on the growth of MDA-MB-231 derived pulmonary metastases (experimental metastases model) in vivo and on overall survival. Results: Intravenous injection of CRAd loaded hMSCs into mice with established MDA-MB-231 pulmonary metastatic disease homed to the tumor site and led to extended mouse survival compared to mice treated with CRAd alone. Conclusion: Injected hMSCs transduced with CRAds suppressed the growth of pulmonary metastases, presumably through viral amplification in the hMSCs. Thus, hMSCs may be an effective platform for the targeted delivery of CRAds to distant cancer sites such as metastatic breast cancer.

Original languageEnglish
Pages (from-to)157-167
Number of pages11
JournalBreast Cancer Research and Treatment
Volume105
Issue number2
DOIs
StatePublished - 1 Oct 2007

Keywords

  • Breast cancer
  • CRAds
  • Cell vehicle
  • Metastases
  • Stem cells
  • Virotherapy

Fingerprint Dive into the research topics of 'Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma'. Together they form a unique fingerprint.

  • Cite this

    Stoff-Khalili, M. A., Rivera, A. A., Mathis, J. M., Banerjee, N. S., Moon, A. S., Hess, A., Rocconi, R. P., Numnum, T. M., Everts, M., Chow, L. T., Douglas, J. T., Siegal, G. P., Zhu, Z. B., Bender, H. G., Dall, P., Stoff, A., Pereboeva, L., & Curiel, D. T. (2007). Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Research and Treatment, 105(2), 157-167. https://doi.org/10.1007/s10549-006-9449-8